Share
Other content recommended for you
- Acceptability of donor funding for clinical trials in the UK: a qualitative empirical ethics study using focus groups to elicit the views of research patient public involvement group members, research ethics committee chairs and clinical researchers
- A Plutocratic Proposal: an ethical way for rich patients to pay for a place on a clinical trial
- From protection to entitlement: selecting research subjects for early phase clinical trials involving breakthrough therapies
- Fair subject selection in clinical research: formal equality of opportunity
- Beyond informed consent: the therapeutic misconception and trust
- Philanthropy on trial: can the rich rescue shelved compounds?
- Equity of resource flows for reproductive, maternal, newborn, and child health: are those most in need being left behind?
- Phase I oncology trials: why the therapeutic misconception will not go away
- Fair and equitable subject selection in concurrent COVID-19 clinical trials
- Stakeholder perceptions of current practices and challenges in priority setting for non-communicable disease control in Kenya: a qualitative study